Skip to content Skip to footer

Prohibition Partners recruit french regulatory advisor as tides turn on french cannabis debate

Prohibition Partners recruit french regulatory advisor as tides turn on french cannabis debate
Share this story
Share on twitter
Share on linkedin
Share on email

Paula joins at a critical time in the French cannabis debate. On 13th December 2018, the French National Agency for Medicines and Health Products Safety (ANSM) recommended the legalisation of medical cannabis, following the publication of the first findings of its Temporary Specialist Scientific Committee (CSST) on medical cannabis. The committee was set up by the ANSM in September 2018 for the duration of one year with the task to evaluate the desirability and feasibility of medical cannabis legalisation in France. The committee found that it is “pertinent to authorise the use of medical cannabis” for patients with certain specified conditions, namely:

  • Chronic pain;
  • Some forms of severe and drug-resistant epilepsy;
  • As part of supportive care in oncology;
  • In palliative situations;
  • For multiple sclerosis spasticity.

The announcement came after a three-month inquiry, kickstarted by the French Health Minister Agnès Buzyn stating that medical cannabis “could happen” in France. The committee, composed of medical professionals and a representative from a patients’ association, also recommended continuing assessment of any patients being treated, and that legislation is put in place to make the drug available. On 30 January 2019, the Committee met again, debating more practical aspects of the how to introduce medical cannabis, e.g. routes of administration.

Paula’s appointment comes just days ahead of the launch of Cannabis Europa Paris. Taking place on 8th February at Maison de la Chime, Cannabis Europa Paris will be the first-ever major global medical cannabis industry event in France. The timing of the event is pivotal with both national attitudes favouring the legalisation of cannabis (recent polling shows that 82% of the French population supports the use of medical cannabis) and multinational bodies, such as The European Parliament and the WHO, examining the legal status of cannabis.

With France widely regarded as the next major European country likely to implement policy changes, following major developments in neighbouring countries, including the United Kingdom, Portugal and Luxembourg, Paula’s expertise and positioning will be an asset to Prohibition Partners’ international operations.

The ECH team will be co-hosting Cannabis Europa Paris this week, if you would like to speak to a member of our team, please get in touch at info@europeancannabisholdings.com to schedule a meeting.

For a full review of the France cannabis market, download The European Cannabis Report:5th Edition.

Recent posts
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad

Catch up on our newest articles that you might have missed

Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...
thomas-kelley--8iE9ykf3Us-unsplash
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad
The recent publishing of the list of CBD products with a valid Novel Foods application by the UK’s Food Safety...